{
    "eid": "2-s2.0-85105971319",
    "title": "Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study",
    "cover-date": "2021-04-29",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "anti-angiogenesis therapy",
        "docetaxel",
        "nintedanib",
        "non-small cell lung cancer",
        "sequential treatment"
    ],
    "authors": [
        "Krittiya Korphaisarn",
        "Pongwut Danchaivijitr",
        "Thanyanan Reungwetwattana",
        "Busayamas Chewaskulyong",
        "Luangyot Thongthieang",
        "Jarin Chindaprasirt",
        "Kunlatida Maneenil",
        "Chirawadee Sathitruangsak",
        "Chanida Vinayanuwattikun"
    ],
    "citedby-count": 3,
    "ref-count": 20,
    "ref-list": [
        "Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs",
        "Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial",
        "Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer",
        "Pembrolizumab for the treatment of non-small-cell lung cancer",
        "Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial",
        "Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer",
        "Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer",
        "A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanism",
        "Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC",
        "Nintedanib plus docetaxel after progression on immune checkpoint inhibitor therapy: insights from VARGADO, a prospective study in patients with lung adenocarcinoma",
        "Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)",
        "High frequency of mutation of epidermal growth factor receptor in lung adenocarcinoma in Thailand",
        "New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada",
        "Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer",
        "Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial",
        "Efficacy of nintedanib and docetaxel in patients with advanced lung adenocarcinoma treated with first-line chemotherapy and second-line immunotherapy in the nintedanib NPU program",
        "Time since start of first-line therapy as a predictive clinical marker for nintedanib in patients with previously treated non-small cell lung cancer",
        "Efficacy and Safety of Nintedanib Plus Docetaxel in Patients with Advanced Lung Adenocarcinoma: Complementary and Exploratory Analyses of the Phase III LUME-Lung 1 Study",
        "Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients",
        "Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial"
    ],
    "affiliation": [
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60026046",
            "affilname": "Faculty of Medicine, Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026046",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60025527",
            "affilname": "Faculty of Medicine, Prince of Songkia University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025527",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60015887",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60005255",
            "affilname": "Rajavithi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005255",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}